But, of course...
"In the United States and Europe, the drug is not expected to go generic until the early 2030s. That delay is due to special regulatory protections that are intended to encourage innovation by extending a brand-name drugmaker’s monopoly."
#NYTimes #GiftedArticle #NovoNordisk #Ozempic #GLP1 #Generics #Obesity #Health
https://www.nytimes.com/2026/03/19/health/ozempic-wegovy-generic-india-china-canada.html



